iLIVER2025，Vol.4Issue(3)：P.199-209,11.DOI:10.1016/j.iliver.2025.100184
Integrated multi-omics analysis identifies TPX2 as a potential prognostic and immunological biomarker in hepatocellular carcinoma
Hui Peng 1Yong-peng Wei 2Xin-bo Liu 3Yu Wang 2Jian-yong Yuan3
作者信息
- 1. Department of General Surgery,Xiangxi Tujia and Miao Autonomous Prefecture Ethnic Traditional Chinese Medicine Hospital,Xiangxi Tujia and Miao Autonomous Prefecture 416000,Hunan,China
- 2. Department of Hepatobiliary Surgery,Eastern Hepatobiliary Surgery Hospital,Naval Medical University,Shanghai 200438,China
- 3. Department of Hepatobiliary Pancreatic Surgery,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200437,China
- 折叠
摘要
关键词
Hepatocellular carcinoma/TPX2/Immune evasion/Biomarker分类
医药卫生引用本文复制引用
Hui Peng,Yong-peng Wei,Xin-bo Liu,Yu Wang,Jian-yong Yuan..Integrated multi-omics analysis identifies TPX2 as a potential prognostic and immunological biomarker in hepatocellular carcinoma[J].iLIVER,2025,4(3):P.199-209,11.
